A novel multi-center study, serving as the largest pilot study for BRCA clinical testing in Nigeria to evaluate treatment & patient outcomes.

Study Outcomes

Feasibility of saliva based BRCA1/2 remote genetic testing

Evaluating feasibility, acceptability, and cost-effectiveness

Patient reported outcome measures

The Multidimensional Impact of Cancer Risk Assessment (MICRA) tool to measure the impact of result disclosure after genetic testing

Prevalence of BRCA1/2 mutation

Proportion of BC patients with BRCA1/ BRCA2 mutations

Patient experience

Evaluating patient perceptions post-surgery
and experience using the educational materials

Treatment related events

Review of type of surgery, medical and radiation therapy, and oncologic outcomes.